Stifel Maintains Buy on Zymeworks, Raises Price Target to $47
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Stifel analyst Stephen Willey maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $40 to $47.
Stifel analyst Stephen Willey maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $40 to $47.